Pharmidex proudly supports International Bowel Disease (IBD) day
May 19, 2024
Combine our strengths for fighting against IBD
Pharmidex has over 22 years experience in the field of offering translatable inflammatory disease models to the pharma/biotech industry with a variety of robust and fully validated models for gastrointestinal disease. Check our "Inflammation" page in our Services for more information.
Contact with [email protected] for collaborate with us
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
Pharmidex provides comprehensive biomarker and cytokine profiling services to support drug discovery and development across respiratory, autoimmune, metabolic and toxicology programmes. Using state-of-the-art bioanalytical platforms, we deliver robust, translational biomarker data to help understand mechanism of action, immune modulation and therapeutic efficacy. Let’s talk about how our biomarker expertise can strengthen your research. 🌐 https://www.pharmidex.com/BIOMARKERS_ANALYSIS
We’re delighted to share that Vasudha Tandon, PhD Principal Scientist at Pharmidex , will be attending the BBMS Gala Dinner 2026 on Thursday 22 January 2026 at the Old Hall, Queens’ College, Cambridge. This special evening, part of Building Bridges in Medical Sciences, brings together leaders from academia, industry, and healthcare to strengthen collaboration across the life sciences. Vasudha is looking forward to meeting fellow attendees and exploring new opportunities to build meaningful scientific partnerships.
